Australia markets open in 47 minutes

Cisen Pharmaceutical Co., Ltd. (603367.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
16.03+0.19 (+1.20%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,476,892
4,462,349
4,066,088
3,782,593
3,674,158
Cost of revenue
1,852,528
1,839,024
1,789,293
1,684,647
1,570,901
Gross profit
2,624,364
2,623,324
2,276,796
2,097,946
2,103,257
Operating expenses
Research development
383,186
374,883
335,169
334,346
309,585
Selling general and administrative
1,404,405
1,432,743
1,391,131
1,316,658
1,238,373
Total operating expenses
1,976,483
2,014,899
1,918,927
1,811,533
1,681,011
Operating income or loss
647,881
608,425
357,868
286,413
422,246
Interest expense
6,811
6,585
4,295
6,097
9,800
Income before tax
608,246
595,857
366,191
336,132
484,516
Income tax expense
77,844
70,430
13,920
2,230
47,156
Income from continuing operations
530,402
525,426
352,271
333,902
437,360
Net income
528,351
521,338
349,959
334,146
438,784
Net income available to common shareholders
528,351
521,338
349,959
334,146
438,784
Basic EPS
0.99
1.15
0.77
0.74
0.97
Diluted EPS
0.99
1.15
0.77
0.74
0.97
Basic average shares
452,572
453,338
454,492
451,549
452,355
Diluted average shares
452,572
453,338
454,492
451,549
452,355